Scientific Posters

Introducing the new multi-protein quantitation mass spectrometric analysis workflow tools for discovery-phase protein scientists.

A middle-level approach simplifies sample preparation and data analysis for the characterization of the fusion protein Blinatumomab.

Digested oligonucleotide IP-RPLC-MS/MS characterizes mRNA sequence, 5’ cap, and 3’ polyA tail.

Introducing the new multi-protein quantitation mass spectrometric analysis workflow tools for discovery-phase protein scientists.

Charge variant mass spectrometry is used for analyzing biotherapeutics with orthogonal and fractionated sampling.

Released N-linked glycans are annotated and structurally disambiguated through automated spectrum analysis.

Digested oligonucleotide IP-RPLC-MS/MS characterizes mRNA sequence, 5’ cap, and 3’ polyA tail.

A middle-level approach simplifies sample preparation and data analysis for the characterization of the fusion protein Blinatumomab.

A liquid chromatography-tandem mass spectrometry workflow is optimized for mRNA sequence mapping.

Computer modeling evaluates the effectiveness of MS1 and MS2 for mRNA sequence confirmation.

The drug-to-antibody ratio of antibody-drug conjugates is determined in biological samples using microflow-liquid chromatography/HRMS.

Disulfide linkages in the complex cysteine-engineered stapled scFv for bispecific antibodies are optimized and characterized.

Different MS label-free quantitation strategies are assessed for therapeutic proteins.

A middle-level approach simplifies sample preparation and data analysis for the characterization of the fusion protein Blinatumomab.

Charge variant mass spectrometry is used for analyzing biotherapeutics with orthogonal and fractionated sampling.

Integrating tryptic digest peptide data with intact MS data using the new Reconstruction Workflow.

A network method builds a sample-specific glycan database for N-linked glycosylation from MS/MS data.

Improve your organization’s efficiency and capability with automated LCMS analysis of synthetic oligos.

Released N-linked glycans are annotated and structurally disambiguated through automated spectrum analysis.

Released N-linked glycans are annotated and structurally disambiguated through automated spectrum analysis.

A real-time informatics pipeline enables the screening of biologics during high-throughput expression.

A liquid chromatography-tandem mass spectrometry workflow is optimized for mRNA sequence mapping.

Histidine hydrogen-deuterium exchange (His-HDX) mass spectrometry identifies protein-ligand interactions.

Released N-linked glycans are annotated and structurally disambiguated through automated spectrum analysis.

Histidine hydrogen-deuterium exchange (His-HDX) mass spectrometry identifies protein-ligand interactions.

Orthogonal techniques are used for LCMS characterization of a lysine-conjugated ADC.

A novel in vitro serum stability assay for antibody therapeutics incorporates internal standards.

Challenges and strategies are discussed in glycan analysis by MAM.

Glycopeptides are characterized without fragmentation using ion mobility.